Table 1 |
|||||||
|
TERC and C-MYC positivity rates for various cytological diagnoses |
|||||||
|
Cytological diagnosis |
Case no. |
TERC positive |
C-MYC positive |
||||
|
|
|||||||
|
Case no. |
% |
P |
Case no. |
% |
P |
||
|
|
|||||||
|
NILM |
132 |
11 |
8.3 |
29 |
22.0 |
||
|
ASC-US |
50 |
10 |
20.0 |
13 |
26.0 |
||
|
LSIL |
21 |
11 |
52.4 |
12 |
57.1 |
||
|
ASC-H |
14 |
9 |
64.3 |
6 |
42.9 |
||
|
HSIL |
23 |
21 |
91.3 |
20 |
87.0 |
||
|
SCC |
3 |
3 |
100.0 |
3 |
100.0 |
||
|
NILM vs. ASC/LSIL |
< 0.01* |
< 0.01* |
|||||
|
ASC/LSIL vs. HSIL/SCC |
< 0.01* |
< 0.01* |
|||||
|
LSIL/lower vs. HSIL/higher |
< 0.01* |
< 0.01* |
|||||
|
|
|||||||
|
† ASC includes ASC-US and ASC-H *P < 0.05: statistically significant difference between 2 categories |
|||||||
|
Chen et al. Diagnostic Pathology 2012 7:40 doi:10.1186/1746-1596-7-40 |
|||||||
